APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dalteparin Sodium

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dalteparin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025199 pages

Choose your research edition.

Industry ResearchDalteparin Sodium Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Dalteparin Sodium Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Dalteparin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dalteparin Sodium Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Dalteparin Sodium Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Dalteparin Sodium market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Dalteparin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dalteparin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dalteparin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dalteparin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dalteparin Sodium include Aspen Oss, Opocrin, Pharma Action, SPL, Yino Pharma Limited, Baxter, Changshan Biochemical, Changzhou Qianhong Bio-pharma and Dongcheng Biochemicals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dalteparin Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dalteparin Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dalteparin Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dalteparin Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.

Dalteparin Sodium Segment by Company

Aspen Oss

Opocrin

Pharma Action

SPL

Yino Pharma Limited

Baxter

Changshan Biochemical

Changzhou Qianhong Bio-pharma

Dongcheng Biochemicals

Dongying Tiandong Pharmaceutical

Pfizer

Nanjing King-friend

Xinbai Pharmaceuticals

Shenzhen Hepalink

Sichuan Deebio

Dalteparin Sodium Segment by Type

Tablet Dalteparin Sodium

Injection Dalteparin Sodium

Dalteparin Sodium Segment by Application

Myocardial Infarction Treatment

Hemodialysis

Others

Dalteparin Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dalteparin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dalteparin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dalteparin Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dalteparin Sodium market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dalteparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dalteparin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dalteparin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dalteparin Sodium Industry Trends Table 2. Dalteparin Sodium Industry Drivers Table 3. Dalteparin Sodium Industry Opportunities and Challenges Table 4. Dalteparin Sodium Industry Restraints Table 5. Global Dalteparin Sodium Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dalteparin Sodium Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dalteparin Sodium Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Dalteparin Sodium Sales Market Share by Manufacturers Table 9. Global Dalteparin Sodium Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Dalteparin Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dalteparin Sodium Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dalteparin Sodium Manufacturers, Product Type & Application Table 13. Global Dalteparin Sodium Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dalteparin Sodium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Dalteparin Sodium Table 17. Major Manufacturers of Injection Dalteparin Sodium Table 18. Global Dalteparin Sodium Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 19. Global Dalteparin Sodium Sales by Type (2021-2026) & (Tons) Table 20. Global Dalteparin Sodium Sales by Type (2027-2032) & (Tons) Table 21. Global Dalteparin Sodium Sales Market Share by Type (2021-2026) Table 22. Global Dalteparin Sodium Sales Market Share by Type (2027-2032) Table 23. Global Dalteparin Sodium Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Dalteparin Sodium Revenue by Type (2021-2026) & (Tons) Table 25. Global Dalteparin Sodium Revenue by Type (2027-2032) & (Tons) Table 26. Global Dalteparin Sodium Revenue Market Share by Type (2021-2026) Table 27. Global Dalteparin Sodium Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Myocardial Infarction Treatment Table 29. Major Manufacturers of Hemodialysis Table 30. Major Manufacturers of Others Table 31. Global Dalteparin Sodium Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Dalteparin Sodium Sales by Application (2021-2026) & (Tons) Table 33. Global Dalteparin Sodium Sales by Application (2027-2032) & (Tons) Table 34. Global Dalteparin Sodium Sales Market Share by Application (2021-2026) Table 35. Global Dalteparin Sodium Sales Market Share by Application (2027-2032) Table 36. Global Dalteparin Sodium Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 37. Global Dalteparin Sodium Revenue by Application (2021-2026) & (Tons) Table 38. Global Dalteparin Sodium Revenue by Application (2027-2032) & (Tons) Table 39. Global Dalteparin Sodium Revenue Market Share by Application (2021-2026) Table 40. Global Dalteparin Sodium Revenue Market Share by Application (2027-2032) Table 41. Global Dalteparin Sodium Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 42. Global Dalteparin Sodium Sales by Region (2021-2026) & (Tons) Table 43. Global Dalteparin Sodium Sales Market Share by Region (2021-2026) Table 44. Global Dalteparin Sodium Sales Forecasted by Region (2027-2032) & (Tons) Table 45. Global Dalteparin Sodium Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Dalteparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 47. North America Dalteparin Sodium Sales by Country (2021-2026) & (Tons) Table 48. North America Dalteparin Sodium Sales by Country (2027-2032) & (Tons) Table 49. Europe Dalteparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 50. Europe Dalteparin Sodium Sales by Country (2021-2026) & (Tons) Table 51. Europe Dalteparin Sodium Sales by Country (2027-2032) & (Tons) Table 52. Asia Pacific Dalteparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 53. Asia Pacific Dalteparin Sodium Sales by Country (2021-2026) & (Tons) Table 54. Asia Pacific Dalteparin Sodium Sales by Country (2027-2032) & (Tons) Table 55. South America, Middle East and Africa Dalteparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. South America, Middle East and Africa Dalteparin Sodium Sales by Country (2021-2026) & (Tons) Table 57. South America, Middle East and Africa Dalteparin Sodium Sales by Country (2027-2032) & (Tons) Table 58. Global Dalteparin Sodium Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Dalteparin Sodium Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Dalteparin Sodium Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Dalteparin Sodium Revenue Market Share by Region (2021-2026) Table 62. Global Dalteparin Sodium Revenue Market Share by Region (2027-2032) Table 63. Aspen Oss Company Information Table 64. Aspen Oss Business Overview Table 65. Aspen Oss Dalteparin Sodium Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Aspen Oss Dalteparin Sodium Product Portfolio Table 67. Aspen Oss Recent Development Table 68. Opocrin Company Information Table 69. Opocrin Business Overview Table 70. Opocrin Dalteparin Sodium Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Opocrin Dalteparin Sodium Product Portfolio Table 72. Opocrin Recent Development Table 73. Pharma Action Company Information Table 74. Pharma Action Business Overview Table 75. Pharma Action Dalteparin Sodium Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Pharma Action Dalteparin Sodium Product Portfolio Table 77. Pharma Action Recent Development Table 78. SPL Company Information Table 79. SPL Business Overview Table 80. SPL Dalteparin Sodium Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. SPL Dalteparin Sodium Product Portfolio Table 82. SPL Recent Development Table 83. Yino Pharma Limited Company Information Table 84. Yino Pharma Limited Business Overview Table 85. Yino Pharma Limited Dalteparin Sodium Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Yino Pharma Limited Dalteparin Sodium Product Portfolio Table 87. Yino Pharma Limited Recent Development Table 88. Baxter Company Information Table 89. Baxter Business Overview Table 90. Baxter Dalteparin Sodium Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Baxter Dalteparin Sodium Product Portfolio Table 92. Baxter Recent Development Table 93. Changshan Biochemical Company Information Table 94. Changshan Biochemical Business Overview Table 95. Changshan Biochemical Dalteparin Sodium Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Changshan Biochemical Dalteparin Sodium Product Portfolio Table 97. Changshan Biochemical Recent Development Table 98. Changzhou Qianhong Bio-pharma Company Information Table 99. Changzhou Qianhong Bio-pharma Business Overview Table 100. Changzhou Qianhong Bio-pharma Dalteparin Sodium Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Changzhou Qianhong Bio-pharma Dalteparin Sodium Product Portfolio Table 102. Changzhou Qianhong Bio-pharma Recent Development Table 103. Dongcheng Biochemicals Company Information Table 104. Dongcheng Biochemicals Business Overview Table 105. Dongcheng Biochemicals Dalteparin Sodium Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Dongcheng Biochemicals Dalteparin Sodium Product Portfolio Table 107. Dongcheng Biochemicals Recent Development Table 108. Dongying Tiandong Pharmaceutical Company Information Table 109. Dongying Tiandong Pharmaceutical Business Overview Table 110. Dongying Tiandong Pharmaceutical Dalteparin Sodium Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Dongying Tiandong Pharmaceutical Dalteparin Sodium Product Portfolio Table 112. Dongying Tiandong Pharmaceutical Recent Development Table 113. Pfizer Company Information Table 114. Pfizer Business Overview Table 115. Pfizer Dalteparin Sodium Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Pfizer Dalteparin Sodium Product Portfolio Table 117. Pfizer Recent Development Table 118. Nanjing King-friend Company Information Table 119. Nanjing King-friend Business Overview Table 120. Nanjing King-friend Dalteparin Sodium Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Nanjing King-friend Dalteparin Sodium Product Portfolio Table 122. Nanjing King-friend Recent Development Table 123. Xinbai Pharmaceuticals Company Information Table 124. Xinbai Pharmaceuticals Business Overview Table 125. Xinbai Pharmaceuticals Dalteparin Sodium Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Xinbai Pharmaceuticals Dalteparin Sodium Product Portfolio Table 127. Xinbai Pharmaceuticals Recent Development Table 128. Shenzhen Hepalink Company Information Table 129. Shenzhen Hepalink Business Overview Table 130. Shenzhen Hepalink Dalteparin Sodium Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Shenzhen Hepalink Dalteparin Sodium Product Portfolio Table 132. Shenzhen Hepalink Recent Development Table 133. Sichuan Deebio Company Information Table 134. Sichuan Deebio Business Overview Table 135. Sichuan Deebio Dalteparin Sodium Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Sichuan Deebio Dalteparin Sodium Product Portfolio Table 137. Sichuan Deebio Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Dalteparin Sodium Distributors List Table 141. Dalteparin Sodium Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Dalteparin Sodium Product Image Figure 2. Global Dalteparin Sodium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dalteparin Sodium Market Size (2021-2032) & (US$ Million) Figure 4. Global Dalteparin Sodium Sales (2021-2032) & (Tons) Figure 5. Global Dalteparin Sodium Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Dalteparin Sodium Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Dalteparin Sodium Image Figure 9. Injection Dalteparin Sodium Image Figure 10. Global Dalteparin Sodium Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 11. Global Dalteparin Sodium Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Dalteparin Sodium Sales Market Share by Type (2021-2032) Figure 13. Global Dalteparin Sodium Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Dalteparin Sodium Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Dalteparin Sodium Revenue Market Share by Type (2021-2032) Figure 16. Myocardial Infarction Treatment Image Figure 17. Hemodialysis Image Figure 18. Others Image Figure 19. Global Dalteparin Sodium Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Dalteparin Sodium Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Dalteparin Sodium Sales Market Share by Application (2021-2032) Figure 22. Global Dalteparin Sodium Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Dalteparin Sodium Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Dalteparin Sodium Revenue Market Share by Application (2021-2032) Figure 25. North America Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 26. North America Dalteparin Sodium Sales Market Share by Country (2021-2032) Figure 27. U.S. Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 28. Canada Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 29. Mexico Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Europe Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 31. Europe Dalteparin Sodium Sales Market Share by Country (2021-2032) Figure 32. Germany Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 33. France Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 34. U.K. Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Italy Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Netherlands Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Asia Pacific Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 38. Asia Pacific Dalteparin Sodium Sales Market Share by Country (2021-2032) Figure 39. China Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 40. Japan Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 41. South Korea Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 42. Southeast Asia Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 43. India Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 44. Australia Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 45. South America, Middle East and Africa Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 46. South America, Middle East and Africa Dalteparin Sodium Sales Market Share by Country (2021-2032) Figure 47. Brazil Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 48. South Africa Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 49. Saudi Arabia Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Turkey Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 51. Argentina Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 52. UAE Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Egypt Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Chile Dalteparin Sodium Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Global Dalteparin Sodium Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Dalteparin Sodium Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Dalteparin Sodium Revenue (2021-2032) & (US$ Million) Figure 58. North America Dalteparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Dalteparin Sodium Revenue (2021-2032) & (US$ Million) Figure 60. Europe Dalteparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Dalteparin Sodium Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Dalteparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Dalteparin Sodium Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Dalteparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Dalteparin Sodium Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Dalteparin Sodium Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet Dalteparin Sodium
  • Injection Dalteparin Sodium
Applications
  • Myocardial Infarction Treatment
  • Hemodialysis
  • Others
Companies covered
  • Aspen Oss
  • Opocrin
  • Pharma Action
  • SPL
  • Yino Pharma Limited
  • Baxter
  • Changshan Biochemical
  • Changzhou Qianhong Bio-pharma
  • Dongcheng Biochemicals
  • Dongying Tiandong Pharmaceutical
  • Pfizer
  • Nanjing King-friend
  • Xinbai Pharmaceuticals
  • Shenzhen Hepalink
  • Sichuan Deebio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dalteparin Sodium Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dalteparin Sodium Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dalteparin Sodium Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dalteparin Sodium Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dalteparin Sodium Market Dynamics
  1. 2.1 Dalteparin Sodium Industry Trends
  2. 2.2 Dalteparin Sodium Industry Drivers
  3. 2.3 Dalteparin Sodium Industry Opportunities and Challenges
  4. 2.4 Dalteparin Sodium Industry Restraints
3 Dalteparin Sodium Market by Manufacturers
  1. 3.1 Global Dalteparin Sodium Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dalteparin Sodium Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dalteparin Sodium Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dalteparin Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dalteparin Sodium Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dalteparin Sodium Manufacturers, Product Type & Application
  7. 3.7 Global Dalteparin Sodium Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dalteparin Sodium Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dalteparin Sodium Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dalteparin Sodium Tier 1, Tier 2, and Tier 3
4 Dalteparin Sodium Market by Type
  1. 4.1 Dalteparin Sodium Type Introduction
  2. 4.1.1 Tablet Dalteparin Sodium
  3. 4.1.2 Injection Dalteparin Sodium
  4. 4.2 Global Dalteparin Sodium Sales by Type
  5. 4.2.1 Global Dalteparin Sodium Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dalteparin Sodium Sales by Type (2021-2032)
  7. 4.2.3 Global Dalteparin Sodium Sales Market Share by Type (2021-2032)
  8. 4.3 Global Dalteparin Sodium Revenue by Type
  9. 4.3.1 Global Dalteparin Sodium Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dalteparin Sodium Revenue by Type (2021-2032)
  11. 4.3.3 Global Dalteparin Sodium Revenue Market Share by Type (2021-2032)
5 Dalteparin Sodium Market by Application
  1. 5.1 Dalteparin Sodium Application Introduction
  2. 5.1.1 Myocardial Infarction Treatment
  3. 5.1.2 Hemodialysis
  4. 5.1.3 Others
  5. 5.2 Global Dalteparin Sodium Sales by Application
  6. 5.2.1 Global Dalteparin Sodium Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dalteparin Sodium Sales by Application (2021-2032)
  8. 5.2.3 Global Dalteparin Sodium Sales Market Share by Application (2021-2032)
  9. 5.3 Global Dalteparin Sodium Revenue by Application
  10. 5.3.1 Global Dalteparin Sodium Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dalteparin Sodium Revenue by Application (2021-2032)
  12. 5.3.3 Global Dalteparin Sodium Revenue Market Share by Application (2021-2032)
6 Global Dalteparin Sodium Sales by Region
  1. 6.1 Global Dalteparin Sodium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dalteparin Sodium Sales by Region (2021-2032)
  3. 6.2.1 Global Dalteparin Sodium Sales by Region (2021-2026)
  4. 6.2.2 Global Dalteparin Sodium Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dalteparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dalteparin Sodium Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dalteparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dalteparin Sodium Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dalteparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dalteparin Sodium Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dalteparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dalteparin Sodium Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dalteparin Sodium Revenue by Region
  1. 7.1 Global Dalteparin Sodium Revenue by Region
  2. 7.1.1 Global Dalteparin Sodium Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dalteparin Sodium Revenue by Region (2021-2026)
  4. 7.1.3 Global Dalteparin Sodium Revenue by Region (2027-2032)
  5. 7.1.4 Global Dalteparin Sodium Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dalteparin Sodium Revenue (2021-2032)
  8. 7.2.2 North America Dalteparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dalteparin Sodium Revenue (2021-2032)
  11. 7.3.2 Europe Dalteparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dalteparin Sodium Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dalteparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dalteparin Sodium Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dalteparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aspen Oss
  2. 8.1.1 Aspen Oss Company Information
  3. 8.1.2 Aspen Oss Business Overview
  4. 8.1.3 Aspen Oss Dalteparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aspen Oss Dalteparin Sodium Product Portfolio
  6. 8.1.5 Aspen Oss Recent Developments
  7. 8.2 Opocrin
  8. 8.2.1 Opocrin Company Information
  9. 8.2.2 Opocrin Business Overview
  10. 8.2.3 Opocrin Dalteparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Opocrin Dalteparin Sodium Product Portfolio
  12. 8.2.5 Opocrin Recent Developments
  13. 8.3 Pharma Action
  14. 8.3.1 Pharma Action Company Information
  15. 8.3.2 Pharma Action Business Overview
  16. 8.3.3 Pharma Action Dalteparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pharma Action Dalteparin Sodium Product Portfolio
  18. 8.3.5 Pharma Action Recent Developments
  19. 8.4 SPL
  20. 8.4.1 SPL Company Information
  21. 8.4.2 SPL Business Overview
  22. 8.4.3 SPL Dalteparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SPL Dalteparin Sodium Product Portfolio
  24. 8.4.5 SPL Recent Developments
  25. 8.5 Yino Pharma Limited
  26. 8.5.1 Yino Pharma Limited Company Information
  27. 8.5.2 Yino Pharma Limited Business Overview
  28. 8.5.3 Yino Pharma Limited Dalteparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Yino Pharma Limited Dalteparin Sodium Product Portfolio
  30. 8.5.5 Yino Pharma Limited Recent Developments
  31. 8.6 Baxter
  32. 8.6.1 Baxter Company Information
  33. 8.6.2 Baxter Business Overview
  34. 8.6.3 Baxter Dalteparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Baxter Dalteparin Sodium Product Portfolio
  36. 8.6.5 Baxter Recent Developments
  37. 8.7 Changshan Biochemical
  38. 8.7.1 Changshan Biochemical Company Information
  39. 8.7.2 Changshan Biochemical Business Overview
  40. 8.7.3 Changshan Biochemical Dalteparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Changshan Biochemical Dalteparin Sodium Product Portfolio
  42. 8.7.5 Changshan Biochemical Recent Developments
  43. 8.8 Changzhou Qianhong Bio-pharma
  44. 8.8.1 Changzhou Qianhong Bio-pharma Company Information
  45. 8.8.2 Changzhou Qianhong Bio-pharma Business Overview
  46. 8.8.3 Changzhou Qianhong Bio-pharma Dalteparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Changzhou Qianhong Bio-pharma Dalteparin Sodium Product Portfolio
  48. 8.8.5 Changzhou Qianhong Bio-pharma Recent Developments
  49. 8.9 Dongcheng Biochemicals
  50. 8.9.1 Dongcheng Biochemicals Company Information
  51. 8.9.2 Dongcheng Biochemicals Business Overview
  52. 8.9.3 Dongcheng Biochemicals Dalteparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dongcheng Biochemicals Dalteparin Sodium Product Portfolio
  54. 8.9.5 Dongcheng Biochemicals Recent Developments
  55. 8.10 Dongying Tiandong Pharmaceutical
  56. 8.10.1 Dongying Tiandong Pharmaceutical Company Information
  57. 8.10.2 Dongying Tiandong Pharmaceutical Business Overview
  58. 8.10.3 Dongying Tiandong Pharmaceutical Dalteparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dongying Tiandong Pharmaceutical Dalteparin Sodium Product Portfolio
  60. 8.10.5 Dongying Tiandong Pharmaceutical Recent Developments
  61. 8.11 Pfizer
  62. 8.11.1 Pfizer Company Information
  63. 8.11.2 Pfizer Business Overview
  64. 8.11.3 Pfizer Dalteparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pfizer Dalteparin Sodium Product Portfolio
  66. 8.11.5 Pfizer Recent Developments
  67. 8.12 Nanjing King-friend
  68. 8.12.1 Nanjing King-friend Company Information
  69. 8.12.2 Nanjing King-friend Business Overview
  70. 8.12.3 Nanjing King-friend Dalteparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Nanjing King-friend Dalteparin Sodium Product Portfolio
  72. 8.12.5 Nanjing King-friend Recent Developments
  73. 8.13 Xinbai Pharmaceuticals
  74. 8.13.1 Xinbai Pharmaceuticals Company Information
  75. 8.13.2 Xinbai Pharmaceuticals Business Overview
  76. 8.13.3 Xinbai Pharmaceuticals Dalteparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Xinbai Pharmaceuticals Dalteparin Sodium Product Portfolio
  78. 8.13.5 Xinbai Pharmaceuticals Recent Developments
  79. 8.14 Shenzhen Hepalink
  80. 8.14.1 Shenzhen Hepalink Company Information
  81. 8.14.2 Shenzhen Hepalink Business Overview
  82. 8.14.3 Shenzhen Hepalink Dalteparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Shenzhen Hepalink Dalteparin Sodium Product Portfolio
  84. 8.14.5 Shenzhen Hepalink Recent Developments
  85. 8.15 Sichuan Deebio
  86. 8.15.1 Sichuan Deebio Company Information
  87. 8.15.2 Sichuan Deebio Business Overview
  88. 8.15.3 Sichuan Deebio Dalteparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sichuan Deebio Dalteparin Sodium Product Portfolio
  90. 8.15.5 Sichuan Deebio Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dalteparin Sodium Value Chain Analysis
  2. 9.1.1 Dalteparin Sodium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dalteparin Sodium Production Mode & Process
  6. 9.2 Dalteparin Sodium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dalteparin Sodium Distributors
  9. 9.2.3 Dalteparin Sodium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst